Cargando…
YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α
Positive evidence from clinical trials has fueled growing acceptance of traditional Chinese medicine (TCM) for the treatment of cardiac diseases; however, little is known about the underlying mechanisms. Here, we investigated the nature and underlying mechanisms of the effects of YiXin-Shu (YXS), an...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786861/ https://www.ncbi.nlm.nih.gov/pubmed/26964694 http://dx.doi.org/10.1038/srep23025 |
_version_ | 1782420615518486528 |
---|---|
author | Zhao, Yichao Xu, Longwei Qiao, Zhiqing Gao, Lingchen Ding, Song Ying, Xiaoying Su, Yuanyuan Lin, Nan He, Ben Pu, Jun |
author_facet | Zhao, Yichao Xu, Longwei Qiao, Zhiqing Gao, Lingchen Ding, Song Ying, Xiaoying Su, Yuanyuan Lin, Nan He, Ben Pu, Jun |
author_sort | Zhao, Yichao |
collection | PubMed |
description | Positive evidence from clinical trials has fueled growing acceptance of traditional Chinese medicine (TCM) for the treatment of cardiac diseases; however, little is known about the underlying mechanisms. Here, we investigated the nature and underlying mechanisms of the effects of YiXin-Shu (YXS), an antioxidant-enriched TCM formula, on myocardial ischemia/reperfusion (MI/R) injury. YXS pretreatment significantly reduced infarct size and improved viable myocardium metabolism and cardiac function in hypercholesterolemic mice. Mechanistically, YXS attenuated myocardial apoptosis by inhibiting the mitochondrial mediated apoptosis pathway (as reflected by inhibition of mitochondrial swelling, cytochrome c release and caspase-9 activity, and normalization of Bcl-2 and Bax levels) without altering the death receptor and endoplasmic reticulum-stress death pathways. Moreover, YXS reduced oxidative/nitrative stress (as reflected by decreased superoxide and nitrotyrosine content and normalized pro- and anti-oxidant enzyme levels). Interestingly, YXS upregulated endogenous nuclear receptors including LXRα, PPARα, PPARβ and ERα, and in-vivo knockdown of cardiac-specific LXRα significantly blunted the cardio-protective effects of YXS. Collectively, these data show that YXS is effective in mitigating MI/R injury by suppressing mitochondrial mediated apoptosis and oxidative stress and by upregulating LXRα, thereby providing a rationale for future clinical trials and clinical applications. |
format | Online Article Text |
id | pubmed-4786861 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-47868612016-03-14 YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α Zhao, Yichao Xu, Longwei Qiao, Zhiqing Gao, Lingchen Ding, Song Ying, Xiaoying Su, Yuanyuan Lin, Nan He, Ben Pu, Jun Sci Rep Article Positive evidence from clinical trials has fueled growing acceptance of traditional Chinese medicine (TCM) for the treatment of cardiac diseases; however, little is known about the underlying mechanisms. Here, we investigated the nature and underlying mechanisms of the effects of YiXin-Shu (YXS), an antioxidant-enriched TCM formula, on myocardial ischemia/reperfusion (MI/R) injury. YXS pretreatment significantly reduced infarct size and improved viable myocardium metabolism and cardiac function in hypercholesterolemic mice. Mechanistically, YXS attenuated myocardial apoptosis by inhibiting the mitochondrial mediated apoptosis pathway (as reflected by inhibition of mitochondrial swelling, cytochrome c release and caspase-9 activity, and normalization of Bcl-2 and Bax levels) without altering the death receptor and endoplasmic reticulum-stress death pathways. Moreover, YXS reduced oxidative/nitrative stress (as reflected by decreased superoxide and nitrotyrosine content and normalized pro- and anti-oxidant enzyme levels). Interestingly, YXS upregulated endogenous nuclear receptors including LXRα, PPARα, PPARβ and ERα, and in-vivo knockdown of cardiac-specific LXRα significantly blunted the cardio-protective effects of YXS. Collectively, these data show that YXS is effective in mitigating MI/R injury by suppressing mitochondrial mediated apoptosis and oxidative stress and by upregulating LXRα, thereby providing a rationale for future clinical trials and clinical applications. Nature Publishing Group 2016-03-11 /pmc/articles/PMC4786861/ /pubmed/26964694 http://dx.doi.org/10.1038/srep23025 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Zhao, Yichao Xu, Longwei Qiao, Zhiqing Gao, Lingchen Ding, Song Ying, Xiaoying Su, Yuanyuan Lin, Nan He, Ben Pu, Jun YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α |
title | YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α |
title_full | YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α |
title_fullStr | YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α |
title_full_unstemmed | YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α |
title_short | YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α |
title_sort | yixin-shu, a shengmai-san-based traditional chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-x-receptor α |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786861/ https://www.ncbi.nlm.nih.gov/pubmed/26964694 http://dx.doi.org/10.1038/srep23025 |
work_keys_str_mv | AT zhaoyichao yixinshuashengmaisanbasedtraditionalchinesemedicineformulaattenuatesmyocardialischemiareperfusioninjurybysuppressingmitochondrialmediatedapoptosisandupregulatingliverxreceptora AT xulongwei yixinshuashengmaisanbasedtraditionalchinesemedicineformulaattenuatesmyocardialischemiareperfusioninjurybysuppressingmitochondrialmediatedapoptosisandupregulatingliverxreceptora AT qiaozhiqing yixinshuashengmaisanbasedtraditionalchinesemedicineformulaattenuatesmyocardialischemiareperfusioninjurybysuppressingmitochondrialmediatedapoptosisandupregulatingliverxreceptora AT gaolingchen yixinshuashengmaisanbasedtraditionalchinesemedicineformulaattenuatesmyocardialischemiareperfusioninjurybysuppressingmitochondrialmediatedapoptosisandupregulatingliverxreceptora AT dingsong yixinshuashengmaisanbasedtraditionalchinesemedicineformulaattenuatesmyocardialischemiareperfusioninjurybysuppressingmitochondrialmediatedapoptosisandupregulatingliverxreceptora AT yingxiaoying yixinshuashengmaisanbasedtraditionalchinesemedicineformulaattenuatesmyocardialischemiareperfusioninjurybysuppressingmitochondrialmediatedapoptosisandupregulatingliverxreceptora AT suyuanyuan yixinshuashengmaisanbasedtraditionalchinesemedicineformulaattenuatesmyocardialischemiareperfusioninjurybysuppressingmitochondrialmediatedapoptosisandupregulatingliverxreceptora AT linnan yixinshuashengmaisanbasedtraditionalchinesemedicineformulaattenuatesmyocardialischemiareperfusioninjurybysuppressingmitochondrialmediatedapoptosisandupregulatingliverxreceptora AT heben yixinshuashengmaisanbasedtraditionalchinesemedicineformulaattenuatesmyocardialischemiareperfusioninjurybysuppressingmitochondrialmediatedapoptosisandupregulatingliverxreceptora AT pujun yixinshuashengmaisanbasedtraditionalchinesemedicineformulaattenuatesmyocardialischemiareperfusioninjurybysuppressingmitochondrialmediatedapoptosisandupregulatingliverxreceptora |